Medical Research

America's Post-Pandemic Bet On Sickness, Not Health
Clinical & Pharma America's Post-Pandemic Bet On Sickness, Not Health

The COVID-19 pandemic served as a brutal, real-world stress test for the nation's health, revealing with devastating clarity that underlying metabolic fitness is a critical defense against severe disease and mortality. Yet, in the years that followed, this profound lesson was not only ignored but

Is Dundee Leading the Fight Against Parkinson's?
Clinical & Pharma Is Dundee Leading the Fight Against Parkinson's?

In a significant development for medical science, a clinical research team in Dundee, Scotland, has garnered international acclaim by becoming a crucial launchpad for one of the world's most anticipated clinical trials for Parkinson's disease. The team achieved a remarkable milestone by activating

Surgical Pouch Heals Animals, Offers Hope for People
Clinical & Pharma Surgical Pouch Heals Animals, Offers Hope for People

In the relentless battle against severe localized infections, traditional systemic antibiotics often fall short, unable to penetrate the complex and hostile environment of an infected wound, a problem that has persisted for decades in modern medicine. These aggressive infections can escalate with

Can You Shape the Future of Public Health in Africa?
Clinical & Pharma Can You Shape the Future of Public Health in Africa?

The African continent stands at a critical juncture, facing a complex dual burden of infectious diseases and a rapidly rising tide of non-communicable chronic conditions that strain already fragile health systems. Addressing these multifaceted challenges requires a new generation of highly skilled,

Is Evidence-Based Medicine Built on a Flawed Foundation?
Clinical & Pharma Is Evidence-Based Medicine Built on a Flawed Foundation?

A significant critique with far-reaching implications for medical research and clinical practice has exposed profound methodological flaws in a widely referenced meta-analysis, igniting an urgent conversation about the very bedrock of modern healthcare. The research, conducted by K. Pai, A. Raghav,

Could Fewer Animal Tests Mean Better Medicines?
Clinical & Pharma Could Fewer Animal Tests Mean Better Medicines?

The journey of a new drug from a laboratory concept to a patient's bedside is notoriously fraught with failure, with a staggering nine out of ten candidates failing in human clinical trials due to unforeseen safety or efficacy issues. This high attrition rate not only represents a massive financial

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later